Incruse Ellipta and Respiratory syncytial virus immune globulin, human Intravenous
Determining the interaction of Incruse Ellipta and Respiratory syncytial virus immune globulin, human Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: respiratory syncytial virus immune globulin
Brand name:
Synonyms: Respiratory syncytial virus immune globulin, human (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-RespiVent Dosepack DF
- Incruse Ellipta-Restall
- Incruse Ellipta-Restoril
- Incruse Ellipta-Retacrit
- Incruse Ellipta-Retapamulin
- Incruse Ellipta-Retapamulin topical
- Respiratory syncytial virus immune globulin, human Intravenous-Indacaterol
- Respiratory syncytial virus immune globulin, human Intravenous-Indacaterol and Glycopyrrolate
- Respiratory syncytial virus immune globulin, human Intravenous-Indacaterol and glycopyrrolate Inhalation
- Respiratory syncytial virus immune globulin, human Intravenous-Indacaterol inhalation
- Respiratory syncytial virus immune globulin, human Intravenous-Indacaterol Maleate
- Respiratory syncytial virus immune globulin, human Intravenous-Indapamide